Both in Biotechnology
Kalaris Therapeutics vs Caribou Biosciences
Over the past year KLRS returned −57.9% and CRBU returned −81.6%; their daily moves had a correlation of 0.15.
KLRS −57.9% CRBU −81.6%Growth of $1, one year, split-adjusted
| Metric | KLRS | CRBU |
|---|---|---|
| Price | $2.10 | $0.4473 |
| Market cap | $50.0M | $48.0M |
| Today | +2.44% | −2.63% |
| 1 month | −21.1% | −60.6% |
| 6 months | −58.5% | −77.1% |
| Year to date | −75.1% | −71.9% |
| 1 year | −57.9% | −81.6% |
| Revenue growth (YoY) | — | −43.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1619.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.8× |
| Net cash | $93.5M | $112.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 146.2% |
| Short % of float | 5.4% | 13.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).